Prognostic and predictive value of low estrogen receptor expression in breast cancer - Wikidata - awgldk - TriplyDB

Prognostic and predictive value of low estrogen receptor expression in breast cancer

Prognostic and predictive value of low estrogen receptor expression in breast cancer

http://www.wikidata.org/entity/Q33611133

about

Prognostic and predictive value of low estrogen receptor expression in breast cancer

http://www.wikidata.org/entity/Q33611133

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Prognostic and predictive value of low estrogen receptor expression in breast cancer

@ast

Prognostic and predictive value of low estrogen receptor expression in breast cancer

@en

type

label

Prognostic and predictive value of low estrogen receptor expression in breast cancer

@ast

Prognostic and predictive value of low estrogen receptor expression in breast cancer

@en

prefLabel

Prognostic and predictive value of low estrogen receptor expression in breast cancer

@ast

Prognostic and predictive value of low estrogen receptor expression in breast cancer

@en

P1433

Q33611133-F1DA3CA3-D0C4-482B-B87F-52017E7664F9

P1476

Q33611133-905C3089-509A-4F1A-9D8A-36E21AC17FD3

P2093

Q33611133-2BA370E3-964B-478D-8A7F-8B424D0239C2

Q33611133-43AE66C7-C75D-404E-B60E-2B51F6365902

Q33611133-AEB79B2A-6D10-4A61-8B11-0FE43C8897A6

Q33611133-EFA5F271-0099-4F06-A25B-1486CC32B619

P2860

Q33611133-00B7B9D2-99DC-4E35-8E91-5837EFE53928

Q33611133-200325C7-0199-4BB8-A67C-803382FA6764

Q33611133-565DDC52-795A-4353-BC04-8BAA2EDDEB77

Q33611133-57D92CD8-5A22-4516-97F8-659487D0C596

Q33611133-637CF6C2-7233-432D-A904-29ABAB1CE39E

Q33611133-7DE72624-DD4F-4030-986D-D34E1DBCB649

Q33611133-87DC6157-6ECA-4417-ADD9-DECED672DDE5

Q33611133-8C48E3B0-D765-47FD-AA9E-C43CDB182994

Q33611133-9596ED3B-43C6-4259-B24F-1B34A9C3002F

Q33611133-A868E221-FDCB-4508-98A2-D86368DDF0CC

P304

Q33611133-A3C4C85F-F78E-4C56-8ACB-6F1211B8016E

P31

Q33611133-A7828899-FAA4-47F7-A87C-F0F36C22D025

P356

Q33611133-8577AFF1-1BCC-45D8-A211-0BD40C2787EF

P433

Q33611133-9073E132-1323-4D38-88F9-BFE1FDC56597

P478

Q33611133-B5237192-B0C3-4947-84FA-E6748EA11780

P577

Q33611133-E68E06A4-8C6E-4136-AF7E-1DDE6FC8DB29

P698

Q33611133-4970C6E1-FD2B-4D14-A2B1-A497A7C4BC29

P932

Q33611133-C5F0719F-2D2D-4DFC-8F68-60ADC7D2A7EF

P356

P1433

Current Oncology

P1476

Prognostic and predictive value of low estrogen receptor expression in breast cancer

@en

P2093

A Bouchard-Fortier

http://www.w3.org/2001/XMLSchema#string

C Blanchette

http://www.w3.org/2001/XMLSchema#string

C Diorio

http://www.w3.org/2001/XMLSchema#string

L Provencher

http://www.w3.org/2001/XMLSchema#string

P2860

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems.

Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status.

P304

e106-e114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.24.3238

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28490933

http://www.w3.org/2001/XMLSchema#string

P932

5407873

http://www.w3.org/2001/XMLSchema#string